Key result
Acute systolic blood pressure lowering safely mitigates risk in select intracerebral hemorrhage patients.
Answers are grounded in this paper and cite their sources.
Review evaluates acute blood pressure lowering strategies after intracerebral hemorrhage, highlighting safe antihypertensive regimens to prevent hematoma expansion and improve survival.
Intracerebral hemorrhage (ICH) is responsible for approximately 15% of strokes annually in the United States, with nearly 1 in 3 of these patients dying without ever leaving the hospital. Because this disproportionate mortality risk has been stagnant for nearly 3 decades, a main area of research has been focused on the optimal strategies to reduce mortality and improve functional outcomes. The acute hypertensive response following ICH has been shown to facilitate ICH expansion and is a strong predictor of mortality. Rapidly reducing blood pressure was once thought to induce cerebral ischemia, though has been found to be safe in certain patient populations. Clinicians must work quickly to determine whether specific patient populations may benefit from acute lowering of systolic blood pressure (SBP) following ICH. This review provides nurses with a summary of the available literature on blood pressure control following ICH. It focuses on intravenous and oral antihypertensive medications available in the United States that may be utilized to acutely lower SBP, as well as medications outside of the antihypertensive class used during the acute setting that may reduce SBP.
No takes yet. Share an insight, caveat, or question.
Haller et al. (2019) conducted a review in Intracerebral hemorrhage. Acute lowering of systolic blood pressure was evaluated. Acute lowering of systolic blood pressure following intracerebral hemorrhage, which causes 15% of strokes and 33% inpatient mortality, may be safely utilized to mitigate risk in certain populations.
Synapse has enriched 10 related papers. Consider them for comparative context: